Giulio Belfiori
Overview
Explore the profile of Giulio Belfiori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
534
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hollenbach M, Heise C, Abou-Ali E, Gulla A, Auriemma F, Soares K, et al.
Gut
. 2024 Dec;
74(3):397-409.
PMID: 39642968
Objective: Ampullary neoplastic lesions can be resected by endoscopic papillectomy (EP) or transduodenal surgical ampullectomy (TSA) while pancreaticoduodenectomy is reserved for more advanced lesions. We present the largest retrospective comparative...
2.
Vanella G, Leone R, Frigo F, Bronswijk M, van Wanrooij R, Tamburrino D, et al.
DEN Open
. 2024 Oct;
5(1):e70024.
PMID: 39377069
Objectives: Malignant double obstruction, defined as the simultaneous presence of biliary and gastric outlet obstruction, represents a challenging clinical scenario. Previous retrospective experiences have demonstrated shorter dysfunction-free survival (DyFS) of...
3.
Tamburrino D, Arcangeli C, De Stefano F, Belfiori G, Macchini M, Orsi G, et al.
Surgery
. 2024 Aug;
176(5):1458-1465.
PMID: 39191599
Background: Pathologic complete response after neoadjuvant treatment in pancreatic ductal adenocarcinoma is a rare occurrence. Similar to other malignancies, achieving a pathologic complete response in pancreatic ductal adenocarcinoma seems to...
4.
Ahola R, Zwart E, Kurlinkus B, Halimi A, Yilmaz B, Belfiori G, et al.
BJS Open
. 2024 Jul;
8(4).
PMID: 39066678
Background: The introduction of the 1 mm cut-off for resection margin according to the Leeds Pathology Protocol has transformed the concept of surgical radicality. Its impact on nodal-positive resected pancreatic...
5.
Crippa S, Malleo G, Mazzaferro V, Langella S, Ricci C, Casciani F, et al.
JAMA Surg
. 2024 Jul;
159(10):1139-1147.
PMID: 39046713
Importance: There are currently no clinically relevant criteria to predict a futile up-front pancreatectomy in patients with anatomically resectable pancreatic ductal adenocarcinoma. Objectives: To develop a futility risk model using...
6.
Stoop T, Oba A, Wu Y, Beaty L, Colborn K, Janssen B, et al.
JAMA Netw Open
. 2024 Jun;
7(6):e2417625.
PMID: 38888920
Importance: Preoperative chemo(radio)therapy is increasingly used in patients with localized pancreatic adenocarcinoma, leading to pathological complete response (pCR) in a small subset of patients. However, multicenter studies with in-depth data...
7.
Passoni P, Reni M, Broggi S, Slim N, Fodor A, Macchini M, et al.
Clin Transl Radiat Oncol
. 2024 May;
47:100778.
PMID: 38779525
Background And Purpose: To assess feasibility, toxicity and outcome of moderately hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic cancer. Materials And Methods: Patients with advanced pancreatic...
8.
Malleo G, Lionetto G, Crippa S, Qadan M, Moser G, Belfiori G, et al.
Ann Surg
. 2024 May;
PMID: 38708617
Objective: To investigate whether revision of pancreatic neck margin based on intraoperative frozen section analysis has oncologic value in post-neoadjuvant pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC). Summary Background Data:...
9.
Fogliati A, Crippa S, Marchegiani G, Belfiori G, Pea A, Graham R, et al.
Pancreatology
. 2024 May;
24(5):747-752.
PMID: 38702207
Background: Mucinous cystic neoplasms (MCN) of the pancreas express estrogen and progesterone receptors. Several case reports describe MCN increasing in size during gestation. The aim of this study is to...
10.
Crippa S, Marchegiani G, Belfiori G, Rancoita P, Pollini T, Burelli A, et al.
Gut
. 2024 Apr;
73(8):1336-1342.
PMID: 38653539
Objective: Cost-effectiveness of surveillance for branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) is debated. We combined different categories of risks of IPMN progression and of IPMN-unrelated mortality to improve surveillance strategies....